You planned your program around the science. Then a 9-month plasmid queue rewrote the schedule.
Industry-average lead time for custom plasmid DNA is 6–9+ months — and counting. For gene therapy, mRNA, and cell therapy programs racing toward IND, that’s not a vendor delay. It’s a redesign of your entire timeline, decided by someone else’s backlog.
Change the input. Change the timeline.
- Speed. Custom plasmids in 2 weeks. GMP material in 4–6 months.
- No licensing strings. Off-the-shelf and custom constructs, free and clear.
- One roof. Research through GMP, all under one purpose-built U.S. facility.
- Built for the hard stuff. Best-in-class yield and purity for mRNA, viral vectors, and cell & gene therapy programs.
“We had GMP plasmid in months, not quarters — and our program never had to wait.”
That’s the difference a purpose-built U.S. plasmid platform makes. Hear it directly from a developer who stopped letting plasmid lead times set the schedule — and got the timeline back.
